BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chesnokova LS, Jiang R, Hutt-Fletcher LM. Viral Entry. Curr Top Microbiol Immunol 2015;391:221-35. [PMID: 26428376 DOI: 10.1007/978-3-319-22834-1_7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Rühl J, Leung CS, Münz C. Vaccination against the Epstein-Barr virus. Cell Mol Life Sci 2020;77:4315-24. [PMID: 32367191 DOI: 10.1007/s00018-020-03538-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
2 Chabay P. Advances in the Pathogenesis of EBV-Associated Diffuse Large B Cell Lymphoma. Cancers (Basel) 2021;13:2717. [PMID: 34072731 DOI: 10.3390/cancers13112717] [Reference Citation Analysis]
3 Rahman R, Gopinath D, Buajeeb W, Poomsawat S, Johnson NW. Potential Role of Epstein–Barr Virus in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma: A Scoping Review. Viruses 2022;14:801. [DOI: 10.3390/v14040801] [Reference Citation Analysis]
4 Sathiyamoorthy K, Hu YX, Möhl BS, Chen J, Longnecker R, Jardetzky TS. Structural basis for Epstein-Barr virus host cell tropism mediated by gp42 and gHgL entry glycoproteins. Nat Commun 2016;7:13557. [PMID: 27929061 DOI: 10.1038/ncomms13557] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 7.7] [Reference Citation Analysis]
5 Wang J, Zheng X, Peng Q, Zhang X, Qin Z. Eph receptors: the bridge linking host and virus. Cell Mol Life Sci 2020;77:2355-65. [PMID: 31893311 DOI: 10.1007/s00018-019-03409-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
6 Sathiyamoorthy K, Jiang J, Möhl BS, Chen J, Zhou ZH, Longnecker R, Jardetzky TS. Inhibition of EBV-mediated membrane fusion by anti-gHgL antibodies. Proc Natl Acad Sci U S A 2017;114:E8703-10. [PMID: 28939750 DOI: 10.1073/pnas.1704661114] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
7 Yu G, Hsu WL, Coghill AE, Yu KJ, Wang CP, Lou PJ, Liu Z, Jones K, Vogt A, Wang M, Mbulaiteye SM, Chen HH, Boland J, Yeager M, Diehl SR, Chen CJ, Hildesheim A, Goldstein AM. Whole-Exome Sequencing of Nasopharyngeal Carcinoma Families Reveals Novel Variants Potentially Involved in Nasopharyngeal Carcinoma. Sci Rep 2019;9:9916. [PMID: 31289279 DOI: 10.1038/s41598-019-46137-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
8 Mühe J, Aye PP, Quink C, Eng JY, Engelman K, Reimann KA, Wang F. Neutralizing antibodies against Epstein-Barr virus infection of B cells can protect from oral viral challenge in the rhesus macaque animal model. Cell Rep Med 2021;2:100352. [PMID: 34337567 DOI: 10.1016/j.xcrm.2021.100352] [Reference Citation Analysis]
9 Guidry JT, Birdwell CE, Scott RS. Epstein-Barr virus in the pathogenesis of oral cancers. Oral Dis 2018;24:497-508. [PMID: 28190296 DOI: 10.1111/odi.12656] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
10 Heldwein EE. gH/gL supercomplexes at early stages of herpesvirus entry. Curr Opin Virol 2016;18:1-8. [PMID: 26849495 DOI: 10.1016/j.coviro.2016.01.010] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]
11 Cui X, Snapper CM. Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases. Front Immunol 2021;12:734471. [PMID: 34691042 DOI: 10.3389/fimmu.2021.734471] [Reference Citation Analysis]
12 Shair KHY, Reddy A, Cooper VS. New Insights from Elucidating the Role of LMP1 in Nasopharyngeal Carcinoma. Cancers (Basel) 2018;10:E86. [PMID: 29561768 DOI: 10.3390/cancers10040086] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]